The T-cell lymphoma panel showed no mutations in RHOA, TET2, DNMT3A, IDH2, and other genes typically altered in TFH-derived and other T-cell lymphomas in both lymph node and BM specimens, further supporting the diagnosis of NMZL. The gene discussed is IDH2; the disease is nodal marginal zone B-cell lymphoma.